117 related articles for article (PubMed ID: 27323154)
1. Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis.
Lu X; Lv XD; Ren YH; Yang WD; Li ZB; Zhang L; Bai XF
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323154
[TBL] [Abstract][Full Text] [Related]
2. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
Kabir F; Apu MNH
Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
[TBL] [Abstract][Full Text] [Related]
6. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
[TBL] [Abstract][Full Text] [Related]
7. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme.
Jiang L; Zhong M; Chen T; Zhu X; Yang H; Lv K
J Cell Mol Med; 2020 Sep; 24(17):10075-10087. PubMed ID: 32696617
[TBL] [Abstract][Full Text] [Related]
8. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme.
Li W; Li K; Zhao L; Zou H
Gene; 2014 Sep; 547(2):346-50. PubMed ID: 24967941
[TBL] [Abstract][Full Text] [Related]
10. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme.
Qi F; Li Q; Lu X; Chen Z
J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050
[TBL] [Abstract][Full Text] [Related]
13. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
14. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms.
Zhang Y; Xia Q; Lin J
Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201
[TBL] [Abstract][Full Text] [Related]
15. Revealing radiotherapy- and chemoradiation-induced pathway dynamics in glioblastoma by analyzing multiple differential networks.
Zhou J; Chen C; Li HF; Hu YJ; Xie HL
Mol Med Rep; 2017 Jul; 16(1):696-702. PubMed ID: 28560382
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.
Wei B; Wang L; Du C; Hu G; Wang L; Jin Y; Kong D
Mol Med Rep; 2015 Apr; 11(4):2548-54. PubMed ID: 25514975
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
[TBL] [Abstract][Full Text] [Related]
18. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
[TBL] [Abstract][Full Text] [Related]
19. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.
Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S
J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate biomarkers for GBM based on WGCNA.
Sun Q; Wang Z; Xiu H; He N; Liu M; Yin L
Sci Rep; 2024 May; 14(1):10692. PubMed ID: 38724609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
